Astera Labs, Inc. (NASDAQ:ALAB) Receives $275.75 Average Target Price from Brokerages

Posted by Brenda Bartman on Jul 26th, 2026

Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twenty-three analysts that are covering the company, MarketBeat reports. Eleven investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $282.00.

A number of brokerages have recently weighed in on ALAB. Susquehanna raised their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Stifel Nicolaus increased their target price on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a report on Wednesday, June 24th. Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Rothschild & Co Redburn assumed coverage on Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target for the company. Finally, Needham & Company LLC boosted their price target on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th.

Read Our Latest Analysis on ALAB

Astera Labs Stock Down 10.8%

Astera Labs stock opened at $291.58 on Friday. The firm has a market capitalization of $49.98 billion, a PE ratio of 197.01, a P/E/G ratio of 3.38 and a beta of 3.66. Astera Labs has a 52 week low of $97.89 and a 52 week high of $499.48. The firm’s 50-day simple moving average is $358.95 and its 200 day simple moving average is $225.66.

Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same period last year, the firm posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts expect that Astera Labs will post 1.86 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other news, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the transaction, the director owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. The trade was a 9.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 139,951 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the transaction, the chief executive officer directly owned 3,929,183 shares in the company, valued at $786,465,269.28. The trade was a 3.44% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 1,676,845 shares of company stock worth $444,928,806. Corporate insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Accel Wealth Management purchased a new stake in shares of Astera Labs in the second quarter valued at $317,000. Handelsbanken Fonder AB lifted its position in Astera Labs by 11.3% during the second quarter. Handelsbanken Fonder AB now owns 44,500 shares of the company’s stock worth $21,494,000 after buying an additional 4,500 shares during the period. Redhawk Wealth Advisors Inc. acquired a new stake in Astera Labs in the 2nd quarter worth about $331,000. Wealthcare Advisory Partners LLC grew its holdings in Astera Labs by 0.9% in the 2nd quarter. Wealthcare Advisory Partners LLC now owns 22,845 shares of the company’s stock valued at $11,035,000 after buying an additional 201 shares during the period. Finally, Focus Financial Network Inc. purchased a new stake in Astera Labs in the 2nd quarter valued at about $711,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.